{"id":253065,"date":"2020-04-24T00:43:24","date_gmt":"2020-04-24T04:43:24","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=253065"},"modified":"2020-04-24T00:43:24","modified_gmt":"2020-04-24T04:43:24","slug":"ph-keen-to-join-russia-led-clinical-trials-for-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2020\/04\/24\/ph-keen-to-join-russia-led-clinical-trials-for-covid-19-vaccine\/","title":{"rendered":"PH keen to join Russia-led clinical trials for Covid-19 vaccine"},"content":{"rendered":"<figure id=\"attachment_239478\" aria-describedby=\"caption-attachment-239478\" style=\"width: 6103px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-239478\" src=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7.jpg\" alt=\"\" width=\"6103\" height=\"4019\" srcset=\"https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7.jpg 6103w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7-300x198.jpg 300w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7-768x506.jpg 768w, https:\/\/canadianinquirer.net\/v1\/wp-content\/uploads\/2019\/12\/22102019jor7-1024x674.jpg 1024w\" sizes=\"auto, (max-width: 6103px) 100vw, 6103px\" \/><\/a><figcaption id=\"caption-attachment-239478\" class=\"wp-caption-text\">FILE: Russian Ambassador to the Philippines Igor Khovaev in Makati City on Tuesday (October 22, 2019). (PNA photo by Joey O. Razon)<\/figcaption><\/figure>\n<p><strong>MANILA<\/strong>\u00a0\u2013 The Philippines is interested in participating in Russia-led clinical trials for a coronavirus disease 2019 (Covid-19) vaccine, Russian Ambassador to Manila Igor Khovaev said Thursday night.<\/p>\n<p>&#8220;The Department of Science and Technology (DOST) of the Philippines has approached the Embassy with a proposal to participate in clinical trials for vaccine development through partnership with a competent Russian institution,&#8221; he told the Philippine News Agency, referring to the State Research Center for Virology and Biotechnology VECTOR.<\/p>\n<p>According to Khovaev, the Novosibirsk-based institute has so far achieved &#8220;promising results&#8221; in the development of a Covid-19 vaccine.<\/p>\n<p>&#8220;We recommended the DOST to get in touch with the said Center,&#8221; he said.<\/p>\n<p>Khovaev also said Russian pharmaceutical company Polysan has offered to donate &#8220;an unlimited supply&#8221; of Cycloferon for Covid-19 patients in the Philippines.<\/p>\n<p>He said the medicine &#8220;has proven effective against a wide variety of viral infections&#8221; and that the same drug was given to Indonesia early April.<\/p>\n<p>&#8220;We officially conveyed the relevant offer to the Philippine partners. As far as I know, it has been under consideration,&#8221; he said.<\/p>\n<p>Khovaev stressed these efforts reflect the improving ties between Russia and the Philippines.<\/p>\n<p>&#8220;Trials and challenges may not be particularly pleasurable but apart from all hardships and ordeals, the Covid-19 crisis provides us with new opportunities,&#8221; he said.<\/p>\n<p>&#8220;I am happy and proud to state that the cooperation and friendship between Russians and Filipinos is a real fact, not propaganda. Our partnership based on common humane values has endured a stiff test with flying colors, thereby creating unprecedented preconditions for developing and strengthening a fruitful collaboration in the post coronavirus period,&#8221; he added.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MANILA\u00a0\u2013 The Philippines is interested in participating in Russia-led clinical trials for a coronavirus disease 2019 (Covid-19) vaccine, Russian Ambassador &hellip;<\/p>\n","protected":false},"author":44,"featured_media":239478,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16,95],"tags":[],"class_list":["post-253065","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-news-ph","mauthors-joyce-ann-l-rocamora","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=253065"}],"version-history":[{"count":2,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253065\/revisions"}],"predecessor-version":[{"id":253067,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/253065\/revisions\/253067"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/239478"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=253065"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=253065"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=253065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}